An Investor’s Guide to Merck & Co.'s Earnings in 2Q15 (Continued from Prior Part) Geographical performance Merck & Co. (MRK) operates in over 140 countries worldwide through its more than 450 ...

Broader Portfolio, Robust Late-Stage Pipeline and Expanded Geographic Presence Position Merck for LeadershipEmerging Markets Expected to Account for More Than 25 Percent of Merck's Pharmaceutical and ...

Merck & Co Inc(NYSE:MRK) recently announced a dividend of $0.73 per share, payable on 2023-10-06, with the ex-dividend date set for 2023-09-14. As investors look forward to this upcoming payment ...

As Merck moves forward with plans to close their Riverside facility, the company remains committed to its West Point location and other sites, writes Nathan Owens for Manufacturing Drive. The ...

Merck, based in Darmstadt, last week reported 2009 earnings of euro366 million ($498.7 million), nearly unchanged from 2008. The company, which makes the cancer drug Erbitux, multiple sclerosis ...

From a geographical perspective, just under half of the company's sales are generated in the United States. Having examined the options trading patterns of Merck & Co, our attention now turns ...

NEW YORK: Merck & Co said it will buy Prometheus Biosciences Inc for about US$10.8bil (RM48bil), picking up a promising experimental treatment for ulcerative colitis and Crohn’s disease and ...